Patrick D. Lamy

Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants

Robert Perrillo, Eugene R. Schiff, Eric M. Yoshida et al. · Hepatology · 2000 · 416 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +15

Phase I/II Trial of the Pharmacokinetics, Safety, and Antiretroviral Activity of Tenofovir Disoproxil Fumarate in Human Immunodeficiency Virus-Infected Adults

Patricia Barditch‐Crovo, Steven G. Deeks, Ann Collier et al. · Antimicrobial Agents and Chemotherapy · 2001 · 333 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

<i>In vitro</i> Selection and Characterization of HIV-1 with Reduced Susceptibility to PMPA

Mark A. Wainberg, Michael D. Miller, Yudong Quan et al. · Antiviral Therapy · 1999 · 247 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +16

Human Immunodeficiency Virus Type 1 Expressing the Lamivudine‐Associated M184V Mutation in Reverse Transcriptase Shows Increased Susceptibility to Adefovir and Decreased Replication Capability In Vitro

Michael D. Miller, Kristin E. Anton, Andrew Mulato et al. · The Journal of Infectious Diseases · 1999 · 133 citations · Full text

Life Sciences, Infectious Diseases, Pharmacokinetics +17

FULMINANT HEPATIC FAILURE RESULTING FROM LAMIVUDINE-RESISTANT HEPATITIS B VIRUS IN A RENAL TRANSPLANT RECIPIENT

Marion G. Peters, Gary Singer, Todd K. Howard et al. · Transplantation · 1999 · 119 citations

Medicine, Infectious Diseases, Nephrology +17